A nurse puts a blood sample from a newborn onto a file card for a rare disease screening. (Photo by: Arno Burgi/picture-alliance/dpa/AP Images)

The Trump ad­min­is­tra­tion dis­band­ed a new­born screen­ing pan­el. Ad­vo­cates now face a hard­er path

Pa­tient groups face a hard­er and un­pre­dictable path go­ing state-by-state to boost screen­ing for rare but treat­able con­di­tions af­ter the Trump ad­min­is­tra­tion dis­band­ed a fed­er­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.